Literature DB >> 7295337

Correlation of thymidine-enhanced incorporation of ara-C in deoxyribonucleic acid with increased cell kill.

P P Major, L Sargent, E M Egan, D W Kufe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7295337     DOI： 10.1016/0006-2952(81)90091-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

Review 1.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

2.  A phase I-II study of combination therapy with thymidine and cytosine arabinoside.

Authors:  R Fram; P Major; E Egan; P Beardsley; D Rosenthal; D Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 3.  Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.

Authors:  P H Ellims
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

4.  Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.

Authors:  F Maehira; R M Gledhill; A J Edwards; M R Norman
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

5.  Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.

Authors:  R M Gledhill; A J Edwards; M R Norman
Journal:  Br J Cancer       Date:  1983-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.